Low prevalence and disease severity of COVID-19 in post liver transplant recipients – a single centre experience
No Thumbnail Available
Authors
Verma, Anita
Khorsandi, Shirin Elizabeth
Dolcet, Annalisa
Prachalias, Andreas
Suddle, Abid
Heaton, Nigel
Jassem, Wayel
Check for full-text access
Issue Date
2020
Type
Article
Language
Keywords
Alternative Title
Abstract
Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is driving a present day global pandemic. Immunosuppressed patients are regarded as a high-risk cohort. The following is a short report on COVID-19 in liver transplant recipients (n = 5) from a high volume UK liver transplant unit with a large follow-up cohort (n = 4500). Based on this limited data, liver transplant recipients appear to have a low incidence of COVID-19, with less severe symptoms than expected, when compared with the general population and other solid organ recipients. This possibly could be related to self-isolation adherence and/or the 'ideal' level of immunosuppression that favourably modulates the immune response to COVID-19.
Description
Citation
Publisher
License
Journal
Liver International
Volume
40
Issue
8